This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Scifluor Life Sciences, Inc., Merck Sharp + Dohme Corp., Preceres Inc.. Active years: 2009-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brookline, MA (US) (2009 - 2014)
- Somerville, MA (US) (2014 - 2023)
Company Filing History:
8 out of 23 
4 out of 2,405 
3 out of 3 
Years Active: 2009-2023
Title: Richard Wayne Heidebrecht, Jr: Innovator in Pharmaceutical Chemistry
Introduction
Richard Wayne Heidebrecht, Jr. is a notable inventor based in Somerville, MA (US), recognized for his significant contributions to pharmaceutical chemistry. With a total of 17 patents to his name, he has made substantial advancements in the field, particularly in the development of fluorinated compounds.
Latest Patents
His latest patents include innovative compounds such as fluorinated integrin antagonists. This invention relates to fluorinated compounds and methods for synthesizing them, along with pharmaceutical compositions that can treat various eye conditions, including macular degeneration and diabetic retinopathy. Another recent patent involves fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives, which are also used as integrin receptor antagonists. These advancements highlight his commitment to addressing critical health issues through innovative chemical solutions.
Career Highlights
Throughout his career, Richard has worked with prominent companies in the pharmaceutical industry, including Scifluor Life Sciences, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that have the potential to improve patient outcomes.
Collaborations
Richard has collaborated with esteemed colleagues such as Ben C Askew and Takeru Furuya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Richard Wayne Heidebrecht, Jr. stands out as a significant figure in the realm of pharmaceutical inventions. His work continues to influence the development of new treatments, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile